기관지확장제 반응 검사에서 속효성 기관지확장제 투여 용량의 차이가 소기도 반응도에 영향을 줄까?
Does the different amount of short-acting bronchodilator drugs have different effects on small airway response in bronchodilator test?
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: It is recommended to use 200 (2 puffs) or 400 (4 puffs) μg of salbutamol in the bronchodilator response (BDR) test. We aimed to compare the difference between these 2 doses with regard to small airway dysfunction. Methods: One hundred sixteen subjects who visited the hospital for diagnosis or follow-up of asthma were consecutively enrolled between June 1 and November 31, 2013. The subjects were randomly assigned to the BDR test at the 2 doses (200 or 400 μg of salbutamol), with physicians blinded to the group each subject was assigned to and undertook the BDR test using the spirometry and impulse oscillometry system (IOS). Results: A total of 116 subjects participated in this study; the mean age was 7.8±3.6 years. The number of participants who were assigned to 2 and 4 puffs groups was 59 and 57, respectively. The mean age was older in the 4 puffs group than in the 2 puffs group (P=0.008). There were no significant difference in spirometric and oscillometric parameters between the 2 and 4 puffs groups. However, in subgroup analysis of asthmatic patients on maintenance therapy (n=21), there was a significant difference in relative changes in Rrs5 between the 2 and 4 puffs groups (16.4%±9.6% vs. 28.7%±8.8%, P=0.035). The forced expiratory volume of 1 second showed a significant correlation with resistance in the 2 puffs group and with reactance in the 4 puffs group. Conclusion: There was a significant relationship between the amounts of bronchodilators administered and the small airway dysfunction in children with asthma on maintenance therapy. Further research is warranted to delineate changes in spirometric and IOS measures in accordance with the different amounts of bronchodilators administered.
Abstract
Purpose: It is recommended to use 200 (2 puffs) or 400 (4 puffs) μg of salbutamol in the bronchodilator response (BDR) test. We aimed to compare the difference between these 2 doses with regard to small airway dysfunction. Methods: One hundred sixteen subjects who visited the hospital for diagnosis or follow-up of asthma were consecutively enrolled between June 1 and November 31, 2013. The subjects were randomly assigned to the BDR test at the 2 doses (200 or 400 μg of salbutamol), with physicians blinded to the group each subject was assigned to and undertook the BDR test using the spirometry and impulse oscillometry system (IOS). Results: A total of 116 subjects participated in this study; the mean age was 7.8±3.6 years. The number of participants who were assigned to 2 and 4 puffs groups was 59 and 57, respectively. The mean age was older in the 4 puffs group than in the 2 puffs group (P=0.008). There were no significant difference in spirometric and oscillometric parameters between the 2 and 4 puffs groups. However, in subgroup analysis of asthmatic patients on maintenance therapy (n=21), there was a significant difference in relative changes in Rrs5 between the 2 and 4 puffs groups (16.4%±9.6% vs. 28.7%±8.8%, P=0.035). The forced expiratory volume of 1 second showed a significant correlation with resistance in the 2 puffs group and with reactance in the 4 puffs group. Conclusion: There was a significant relationship between the amounts of bronchodilators administered and the small airway dysfunction in children with asthma on maintenance therapy. Further research is warranted to delineate changes in spirometric and IOS measures in accordance with the different amounts of bronchodilators administered.
참고문헌 (18)
- Tse SM, "Diagnostic accuracy of the bronchodilator response in children", J Allergy Clin Immunol, 132, pp.554~559 (2013)
- Tan WC, "Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study", Thorax, 67, pp.718~726 (2012)
- Shin YH, "Oscillometric and spirometric bronchodilator response in preschool children with and without asthma", Can Respir J, 19, pp.273~277 (2012)
- "Global strategy for asthma management and prevention"[URL]
- 서보선, "소아천식 환자에서 충격진동법과 폐활량기로 측정한 소기도 장애와 호기산화질소와의 관계", Allergy Asthma & Respiratory Diseases, 3(4), pp.267~271 (2015), 대한 소아알레르기 호흡기학회[DOI]
- del Giudice MM, "Fractional exhaled nitric oxide (FENO), lung function and airway hyperresponsiveness in naïve atopic asthmatic children", J Asthma, 41, pp.759~765 (2004)
- Miller MR, "Standardisation of spirometry", Eur Respir J, 26, pp.319~338 (2005)
- Oostveen E, "The forced oscillation technique in clinical practice: methodology, recommendations and future developments", Eur Respir J, 22, pp.1026~1041 (2003)
- Quanjer PH, "Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations", Eur Respir J, 40, pp.1324~1343 (2012)
- Frei J, "Impulse oscillometry: reference values in children 100 to 150 cm in height and 3 to 10 years of age", Chest, 128, pp.1266~1273 (2005)
- Calogero C, "Respiratory impedance and bronchodilator responsiveness in healthy children aged 2-13 years", Pediatr Pulmonol, 48, pp.707~715 (2013)
- Oostveen E, "Respiratory impedance in healthy subjects: baseline values and bronchodilator response", Eur Respir J, 42, pp.1513~1523 (2013)
- López-Campos JL, "A comprehensive, national survey of spirometry in Spain: current bottlenecks and future directions in primary and secondary care", Chest, 144, pp.601~609 (2013)
- Nelson HS, "The bronchodilator response to inhalation of increasing doses of aerosolized albuterol", J Allergy Clin Immunol, 72, pp.371~375 (1983)
- Denjean A, "Dose-related bronchodilator response to aerosolized salbutamol (albuterol) in ventilator-dependent premature infants", J Pediatr, 120, pp.974~979 (1992)
- Rodriguez-Carballeira M, "The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients", Pulm Pharmacol Ther, 14, pp.61~65 (2001)
- Zainudin BM, "Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma", Thorax, 43, pp.987~991 (1988)
- Kradjan WA, "Effect of age on bronchodilator response", Chest, 101, pp.1545~1551 (1992)